FOLD

0.00

100.00% -14.49

Dopo l'orario di chiusura: 14.49 14.49 +

Amicus Therapeutics Inc (FOLD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché FOLD Giù? Forum Previsione

Precedente Chiudi:

$14.49

Aprire:

Volume 24 ore:

Relative Volume:

0.00

Capitalizzazione di mercato:

$4.55B

Reddito:

$634.21M

Utile/perdita netta:

$-27.11M

Rapporto P/E:

0.00

EPS:

-0.0885

Flusso di cassa netto:

$29.85M

1 W Prestazione:

-100.00%

1M Prestazione:

-100.00%

6M Prestazione:

-100.00%

1 anno Prestazione:

-100.00%

Intervallo 1D:

$0.00

Intervallo di 1 settimana:

$0.00

Portata 52W:

$0.00

$14.50

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Nome

Amicus Therapeutics Inc

Settore

Healthcare (1104)

Industria

Biotechnology (617)

Telefono

(609) 662-2000

Indirizzo

47 HULFISH STREET, PRINCETON, NJ

Dipendente

511

Cinguettio

@amicusrx1

Prossima data di guadagno

2026-05-07

Ultimi documenti SEC

FOLD's Discussions on Twitter

Compare FOLD vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FOLD Amicus Therapeutics Inc	0.00	4.55B	634.21M	-27.11M	29.85M	-0.0885
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-22	Downgrade	Jefferies	Buy → Hold
2025-12-29	Downgrade	Leerink Partners	Outperform → Market Perform
2025-12-22	Downgrade	TD Cowen	Buy → Hold
2025-12-17	Iniziato	Citigroup	Buy
2025-09-18	Aggiornamento	Needham	Hold → Buy
2025-07-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-13	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-09-06	Iniziato	Jefferies	Buy
2024-05-30	Iniziato	Wells Fargo	Overweight
2024-05-14	Aggiornamento	Guggenheim	Neutral → Buy
2023-12-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-09-09	Iniziato	Morgan Stanley	Equal-Weight
2022-04-13	Ripresa	Goldman	Neutral
2022-01-14	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-11-15	Aggiornamento	Stifel	Hold → Buy
2021-09-30	Aggiornamento	JP Morgan	Neutral → Overweight
2021-07-19	Ripresa	BTIG Research	Buy
2021-05-27	Iniziato	Needham	Hold
2021-05-21	Iniziato	UBS	Buy
2021-04-14	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2021-03-02	Iniziato	Stifel	Hold
2021-02-12	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-02-12	Downgrade	JP Morgan	Overweight → Neutral
2020-12-28	Ripresa	Cantor Fitzgerald	Overweight
2020-12-10	Downgrade	Citigroup	Buy → Neutral
2020-11-11	Iniziato	Berenberg	Hold
2020-06-17	Iniziato	BTIG Research	Buy
2020-02-04	Ripresa	Cantor Fitzgerald	Overweight
2019-11-12	Reiterato	H.C. Wainwright	Buy
2019-06-17	Iniziato	H.C. Wainwright	Buy
2019-06-05	Reiterato	Cantor Fitzgerald	Overweight
2019-04-05	Iniziato	Janney	Buy
2019-01-30	Iniziato	Cantor Fitzgerald	Overweight
2018-10-29	Iniziato	Citigroup	Neutral
2018-08-17	Downgrade	Chardan Capital Markets	Buy → Neutral
2017-10-06	Ripresa	Goldman	Neutral
2017-09-13	Reiterato	Chardan Capital Markets	Buy
2017-08-10	Reiterato	Chardan Capital Markets	Buy
2017-01-24	Aggiornamento	Robert W. Baird	Neutral → Outperform
2016-05-18	Iniziato	BofA/Merrill	Buy
2016-04-14	Iniziato	Robert W. Baird	Neutral
2016-04-12	Reiterato	Chardan Capital Markets	Buy
2015-09-16	Downgrade	Chardan Capital Markets	Buy → Neutral
2015-06-16	Reiterato	Chardan Capital Markets	Buy

Mostra tutto

Amicus Therapeutics Inc Borsa (FOLD) Ultime notizie

Jun 18, 2026